Tectonic Therapeutic, Inc. (TECX)
↓ Download CSVKey ratios (FY2025)
-29.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$84.04M | -$58.02M | -$44.65M | -$105.43M | -$118.84M | -$120.23M | -$75.81M | -$46.24M | -$18.39M | — |
| Net Income | -$74.15M | -$57.98M | -$42.82M | -$105.89M | -$119.13M | -$119.71M | -$72.97M | -$46.36M | -$18.65M | — |
| EPS (Diluted) | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 | — | — | — | — | — |
| Total Assets | $261.04M | $152.91M | $39.40M | $103.95M | $203.84M | $271.23M | $200.51M | $133.48M | $7.02M | — |
| Total Liabilities | $9.71M | $12.13M | $43.41M | $28.58M | $34.36M | $16.89M | $14.50M | $11.29M | $3.66M | — |
| Shareholders' Equity | $251.33M | $140.78M | -$84.64M | -$45.65M | $169.48M | $254.34M | $186.01M | $122.18M | -$23.14M | -$4.58M |
| Cash & Equivalents | $253.80M | $141.24M | $28.77M | $92.56M | $189.57M | $259.68M | $187.04M | $126.30M | $5.96M | — |
| Operating Cash Flow | -$60.08M | -$59.08M | -$40.68M | -$97.21M | -$98.03M | -$98.80M | -$67.67M | -$37.65M | -$16.38M | — |
| Capital Expenditures | $208.0K | $156.0K | $279.0K | $267.0K | $2.46M | $1.18M | $1.58M | $1.83M | $383.0K | — |
| Shares Outstanding | 18.74M | 14.86M | 1.41M | 43.92M | 43.65M | 43.65M | 31.64M | 23.81M | 2.31M | — |
| Dividends Per Share | $0.00 | $0.00 | — | — | — | — | — | — | — | — |